A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1997
11/04/1997	US5683884 Incubation of eukarotic cells with transformed or transfected with dna sequences for gene expression
11/04/1997	US5683874 Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence
11/04/1997	US5683873 EGS-mediated inactivation of target RNA
11/04/1997	US5683865 Method for diagnosis of mystery swine disease
11/04/1997	US5683714 Liposomal cyclosporin pharmaceutical formulation
11/04/1997	US5683701 Peptide fragments of HIV
11/04/1997	US5683699 Meningococcal polysaccharide conjugate vaccine
11/04/1997	US5683696 Cloning of duffy blood group antigen, gpD
11/04/1997	US5683694 Method for the treatment of tumors with conjugated antibody A5B7 and a prodrug
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	US5683692 Use of RIPonucleases for treating parasitic and viral diseases
11/04/1997	US5683690 Canine lymphoma and feline leukemia
11/04/1997	US5683688 Unglycosylated recombinant human lymphotoxin polypeptides and compositions
11/04/1997	US5683675 Method of treating retained pulmonary secretions
11/04/1997	US5683674 Antibody against human mucin core protein and method of preparing and using same
10/1997
10/30/1997	WO1997040388A1 Peptides having specific affinity to pacap type 1 receptors
10/30/1997	WO1997040358A1 Markers for multidrug resistant cancers
10/30/1997	WO1997040215A1 Myocardial infarction remedy containing anti-il-8 antibody as active ingredient
10/30/1997	WO1997040192A1 Novel protein - traf6
10/30/1997	WO1997040183A2 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/30/1997	WO1997040177A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	WO1997040176A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
10/30/1997	WO1997040170A2 Functional expression of heterologous adenylyl cyclase
10/30/1997	WO1997040168A1 Hepatitis g virus protease
10/30/1997	WO1997040167A1 Porcine retrovirus
10/30/1997	WO1997040164A1 Hepatitis b monoclonal antibodies
10/30/1997	WO1997040161A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
10/30/1997	WO1997040159A1 Characterization of transfer factors and methods of use
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040157A1 Matrix metalloprotease
10/30/1997	WO1997040155A1 Protein mediating neuronal-glial interaction, dna encoding the same, and methods of use thereof
10/30/1997	WO1997040153A1 Al-2 neurotrophic factor
10/30/1997	WO1997040152A1 Glial cell line-derived neurotrophic factor receptor
10/30/1997	WO1997040151A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040150A1 Novel proteins c16 and c16n or genes encoding the same
10/30/1997	WO1997040149A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997	WO1997040148A2 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
10/30/1997	WO1997040147A1 Antigenically reactive regions of the hepatitis a virus polyprotein
10/30/1997	WO1997040145A1 Inactivation resistant factor viii
10/30/1997	WO1997040143A1 Apoptosis inducing protein and gene encoding the same
10/30/1997	WO1997040142A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	WO1997040134A2 Human dnase ii
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040072A2 Adam proteins and uses thereof
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040070A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040068A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	WO1997040064A1 Human netrin-1
10/30/1997	WO1997040063A2 Pathogenic escherichia coli associated protein espa
10/30/1997	WO1997040059A1 Tumor suppressor gene
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	WO1997039775A1 Cerebral stroke/cerebral edema preventive or remedy containing il-8 binding inhibitor as active ingredient
10/30/1997	WO1997039774A1 Human monoclonal antibody specific for melanoma-associated antigen and methods of use
10/30/1997	WO1997039773A1 A method of treating bacterial infection of sutures and prosthetic devices
10/30/1997	WO1997039772A1 Rheumatoid arthritis remedy containing anti-il-8 antibody as active ingredient
10/30/1997	WO1997039770A1 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
10/30/1997	WO1997039769A1 Drug composition comprising albumin as active ingredient
10/30/1997	WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997	WO1997039767A1 Methods for inducing bone formation
10/30/1997	WO1997039766A1 Regulation of cellular volume via chloride conductive polypeptide channels
10/30/1997	WO1997039765A1 Component b as cicatrizant
10/30/1997	WO1997039764A1 Antipylori agent
10/30/1997	WO1997039763A1 Compositions comprising antifungal agent and acetate buffer
10/30/1997	WO1997039762A1 Stabilized antihepatitis-b vaccine tablets
10/30/1997	WO1997039761A1 A process for viral inactivation of lyophilized blood proteins
10/30/1997	WO1997039760A1 Combination therapy for treatment of erectile dysfunction
10/30/1997	WO1997039738A2 Sustained release ionic conjugate
10/30/1997	WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	WO1997039641A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/30/1997	WO1997039629A1 Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor
10/30/1997	WO1997035989A3 Cyclic nucleotide phosphodiesterase
10/30/1997	WO1997035021A3 Prostate specific antigen oligo-epitope peptide
10/30/1997	WO1997034567A3 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
10/30/1997	WO1997029779A3 EGF-Genistein conjugates for the treatment of cancer
10/30/1997	WO1997025426A3 Compositions and methods for the treatment and diagnosis of breast cancer
10/30/1997	WO1997025070A3 Lipophilic peptides for macromolecule delivery
10/30/1997	WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997	DE19616486A1 Verfahren zur Senkung des Blutglukosespiegels in Säugern A method for lowering blood glucose levels in mammals
10/30/1997	CA2285184A1 Stabilized antihepatitis-b vaccine tablets
10/30/1997	CA2253249A1 Novel proteins c16 and c16n or genes encoding the same
10/30/1997	CA2252826A1 Sustained release ionic conjugate
10/30/1997	CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	CA2252509A1 Matrix metalloprotease
10/30/1997	CA2252484A1 A method of treating bacterial infection of sutures and prosthetic devices
10/30/1997	CA2252467A1 Antipylori agent
10/30/1997	CA2252458A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	CA2252439A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	CA2252369A1 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
10/30/1997	CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997	CA2251977A1 Antigenically reactive regions of the hepatitis a virus polyprotein
10/30/1997	CA2251943A1 Characterization of transfer factors and methods of use
10/30/1997	CA2251939A1 Porcine retrovirus
10/30/1997	CA2251934A1 Secreted proteins and polynucleotides encoding them
10/30/1997	CA2251808A1 Methods for inducing bone formation
10/30/1997	CA2251727A1 Regulation of cellular volume via chloride conductive polypeptide channels
10/30/1997	CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy

1 ... 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 ... 3163